THE ROLE OF REDUCTIVE AND OXIDATIVE-METABOLISM IN THE TOXICITY OF MITOXANTRONE, ADRIAMYCIN AND MENADIONE IN HUMAN-LIVER DERIVED HEP-G2 HEPATOMA-CELLS

被引：51
作者：
DUTHIE, SJ [1 ]
GRANT, MH [1 ]
机构：
[1] UNIV ABERDEEN,DEPT MED & THERAPEUT,CLIN PHARMACOL UNIT,ABERDEEN AB9 2ZD,SCOTLAND
来源：
BRITISH JOURNAL OF CANCER | 1989年 / 60卷 / 04期
基金：
英国惠康基金;
关键词：
D O I：
10.1038/bjc.1989.314
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：566 / 571
页数：6
相关论文
共 36 条
[1]  
ANUFORO DC, 1978, IN VITRO CELL DEV B, V14, P981
[2]   ANTITUMOR ANTHRACYCLINES - RECENT DEVELOPMENTS [J].
ARCAMONE, F .
MEDICINAL RESEARCH REVIEWS, 1984, 4 (02) :153-188
[3]   PROTECTIVE ROLE OF THE GLUTATHIONE REDOX CYCLE AGAINST ADRIAMYCIN-MEDIATED TOXICITY IN ISOLATED HEPATOCYTES [J].
BABSON, JR ;
ABELL, NS ;
REED, DJ .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (16) :2299-2304
[4]  
BASRA J, 1985, ANTI-CANCER DRUG DES, V1, P45
[5]  
BUTLER J, 1987, British Journal of Cancer, V55, P53
[6]   MUTAGENICITY OF QUINONES - PATHWAYS OF METABOLIC-ACTIVATION AND DETOXIFICATION [J].
CHESIS, PL ;
LEVIN, DE ;
SMITH, MT ;
ERNSTER, L ;
AMES, BN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (06) :1696-1700
[7]   MITOXANTRONE FOR THE TREATMENT OF ADVANCED BREAST-CANCER - SINGLE-AGENT THERAPY IN PREVIOUSLY UNTREATED PATIENTS [J].
CORNBLEET, MA ;
STUARTHARRIS, RC ;
SMITH, IE ;
COLEMAN, RE ;
RUBENS, RD ;
MCDONALD, M ;
MOURIDSEN, HT ;
RAINER, H ;
VANOOSTEROM, AT ;
SMYTH, JF .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (09) :1141-1146
[8]   MITOXANTRONE AFFECTS TOPOISOMERASE ACTIVITIES IN HUMAN-BREAST CANCER-CELLS [J].
CRESPI, MD ;
IVANIER, SE ;
GENOVESE, J ;
BALDI, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 136 (02) :521-528
[9]   MENADIONE-INDUCED CYTO-TOXICITY IS ASSOCIATED WITH PROTEIN THIOL OXIDATION AND ALTERATION IN INTRACELLULAR CA-2+ HOMEOSTASIS [J].
DIMONTE, D ;
BELLOMO, G ;
THOR, H ;
NICOTERA, P ;
ORRENIUS, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1984, 235 (02) :343-350
[10]  
DOROSHOW JH, 1983, BIOCHEM PHARMACOL, V32, P293
1234